Enveric Biosciences (ENVB) Other Operating Expenses (2015 - 2026)
Enveric Biosciences (ENVB) reported Other Operating Expenses of $36,826 for Q2 2026, down 7.9% from $39,980 a year earlier and down 1.1% from the prior quarter.
Enveric Biosciences (ENVB) Other Operating Expenses (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Enveric Biosciences' Other Operating Expenses came in at $153,920, down 46.6% year-over-year; for FY2025, it was $200,858, down 40.5% from FY2024.
- Other Operating Expenses has declined for four consecutive years, though with a five-year compound annual growth rate of 10.7% (FY2020 to FY2025).
- By year, Other Operating Expenses came in at $337,489 in FY2024 (-1.9%), $343,982 in FY2023 (-95.6%), $7.78 million in FY2022 (-80.2%) and $39.34 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Other Operating Expenses since Q3 2018.
- Year over year, Other Operating Expenses has now declined in each of the last 12 quarters, with an average decline of 28.6% over the last eight quarters.
- The high point for year-over-year Other Operating Expenses in five years was Q1 2023 (growth of 24.9%); the low point was Q4 2023 (a decline of 98.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $37,240 (Q1 2026), $39,485 (Q4 2025) and $40,369 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Enveric Biosciences | 5.86 Mn | -15.78 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36,826.00 |
| Mar 31, 2026 | 37,240.00 |
| Dec 31, 2025 | 39,485.00 |
| Sep 30, 2025 | 40,369.00 |
| Jun 30, 2025 | 39,980.00 |
| Mar 31, 2025 | 81,024.00 |
| Dec 31, 2024 | 82,487.00 |
| Sep 30, 2024 | 84,814.00 |
| Jun 30, 2024 | 84,779.00 |
| Mar 31, 2024 | 85,409.00 |
| Dec 31, 2023 | 84,682.00 |
| Sep 30, 2023 | 86,296.00 |
| Jun 30, 2023 | 86,518.00 |
| Mar 31, 2023 | 86,486.00 |
| Dec 31, 2022 | 7.54 Mn |
| Sep 30, 2022 | 86,646.00 |
| Jun 30, 2022 | 85,502.00 |
| Mar 31, 2022 | 69,265.00 |
| Dec 31, 2021 | 38.85 Mn |
| Sep 30, 2021 | 173,696.00 |
Enveric Biosciences Other Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=ENVB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-operating-expenses", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();